Ibtrozi Capsule
Product Images NDC 84651-200

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ibtrozi (NDC 84651-200). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nuvation Bio Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Ibt00 0001 01)

Figure 1 (Ibt00 0001 01)
Chemical structure of taletrectinib, the active ingredient in IBTROZI 272 mg capsules, shown as a molecular diagram with rings and functional groups including fluorine and carboxylic acid moieties.*
FDA Label Image

Principal Display Panel – 200 mg Carton Label (Ibt00 0001 02)

Principal Display Panel – 200 mg Carton Label (Ibt00 0001 02)
Bottle carton label for IBTROZI (taletrectinib) capsules, 200 mg, distributed by Nuvation Bio Inc. The label shows a 90-capsule total count, containing three bottles with 30 capsules each. The label includes storage instructions, origin (China), and a barcode.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.